Takeda Enters Generics Space With Teva Tie-Up
This article was originally published in Scrip
Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Co. Ltd. are to create a joint business venture to boost the supply of generics to the Japanese market. The new business will be 51% owned by Teva and 49% by Takeda.
Register for our free email digests: